Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Medical Devices Pipeline Assessment, 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global Research focused on the <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong><br />
<strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Medical</strong> <strong>Devices</strong> <strong>Pipeline</strong><br />
<strong>Assessment</strong>, <strong>2016</strong><br />
"The Report <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong><br />
(<strong>DEB</strong>) <strong>Medical</strong> <strong>Devices</strong> <strong>Pipeline</strong> <strong>Assessment</strong>, <strong>2016</strong> provides information on pricing,<br />
market analysis, shares, forecast, and company profiles for key industry participants. <br />
MarketResearchReports.biz"<br />
GlobalData's <strong>Medical</strong> <strong>Devices</strong> sector report, <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong><br />
<strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Medical</strong> <strong>Devices</strong> <strong>Pipeline</strong> <strong>Assessment</strong>, <strong>2016</strong>"<br />
provides an overview of <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong><br />
<strong>Balloons</strong> (<strong>DEB</strong>) currently in pipeline stage.<br />
The report provides comprehensive information on the pipeline products with comparative<br />
analysis of the products at various stages of development. The report reviews major players<br />
involved in the pipeline product development. It also provides information about clinical<br />
trials in progress, which includes trial phase, trial status, trial start and end dates, and, the<br />
number of trials for the key <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong><br />
<strong>Balloons</strong> (<strong>DEB</strong>) pipeline products.<br />
This report is prepared using data sourced from inhouse databases, secondary and primary<br />
research by GlobalData's team of industry experts.<br />
Download Sample copy of this Report @<br />
http://www.marketresearchreports.biz/sample/sample/774322<br />
Scope<br />
Extensive coverage of the <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong><br />
<strong>Balloons</strong> (<strong>DEB</strong>) under development<br />
The report reviews details of major pipeline products which includes, product description,<br />
licensing and collaboration details and other developmental activities<br />
The report reviews the major players involved in the development of <strong>Peripheral</strong><br />
<strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) and list all their pipeline<br />
projects
The coverage of pipeline products based on various stages of development ranging from<br />
Early Development to Approved / Issued stage<br />
The report provides key clinical trial data of ongoing trials specific to pipeline products<br />
Recent developments in the segment / industry<br />
Reasons to buy<br />
The report enables you to <br />
Formulate significant competitor information, analysis, and insights to improve R&D<br />
strategies<br />
Identify emerging players with potentially strong product portfolio and create effective<br />
counterstrategies to gain competitive advantage<br />
Identify and understand important and diverse types of <strong>Peripheral</strong> <strong>Transluminal</strong><br />
<strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) under development<br />
Develop marketentry and market expansion strategies<br />
Plan mergers and acquisitions effectively by identifying major players with the most<br />
promising pipeline<br />
Indepth analysis of the products current stage of development, territory and estimated<br />
launch date<br />
Table of Content :<br />
1 Table of Contents 2<br />
1.1 List of Tables 5<br />
1.2 List of Figures 7<br />
2 Introduction 8<br />
2.1 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) Overview<br />
8<br />
3 Products under Development 9<br />
3.1 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products by Stage of Development 9<br />
3.2 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products by Territory 10<br />
3.3 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products by Regulatory Path 11<br />
3.4 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products by Estimated Approval Date 12<br />
3.5 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) Ongoing<br />
Clinical Trials 13<br />
4 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products under Development by Companies 14<br />
4.1 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>)<br />
Companies <strong>Pipeline</strong> Products by Stage of Development 14
4.2 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) <strong>Pipeline</strong><br />
Products by Stage of Development 15<br />
5 <strong>Peripheral</strong> <strong>Transluminal</strong> <strong>Angioplasty</strong> <strong>Peripheral</strong> <strong>Drug</strong> <strong>Eluting</strong> <strong>Balloons</strong> (<strong>DEB</strong>) Companies<br />
and Product Overview 16<br />
5.1 AnGes MG, Inc. Company Overview 16<br />
5.1.1 AnGes MG, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 16<br />
5.2 AngioCure, Inc. Company Overview 18<br />
5.2.1 AngioCure, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 18<br />
5.3 AVIDAL Vascular GmbH Company Overview 19<br />
5.3.1 AVIDAL Vascular GmbH <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 19<br />
5.4 Bayer HealthCare AG Company Overview 20<br />
5.4.1 Bayer HealthCare AG <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 20<br />
5.5 Contego <strong>Medical</strong>, LLC Company Overview 22<br />
5.5.1 Contego <strong>Medical</strong>, LLC <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 22<br />
5.6 Elixir <strong>Medical</strong> Corporation Company Overview 23<br />
5.6.1 Elixir <strong>Medical</strong> Corporation <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 23<br />
5.7 eucatech AG Company Overview 24<br />
5.7.1 eucatech AG <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 24<br />
5.8 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 25<br />
5.8.1 Lifetech Scientific (Shenzhen) Co., Ltd. <strong>Pipeline</strong> Products & Ongoing Clinical Trials<br />
Overview 25<br />
5.9 Medtronic plc Company Overview 26<br />
5.9.1 Medtronic plc <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 26<br />
5.10 Micell Technologies, Inc. Company Overview 28<br />
5.10.1 Micell Technologies, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 28<br />
5.11 Nipro Corporation Company Overview 30<br />
5.11.1 Nipro Corporation <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 30<br />
5.12 NuVascular Technologies Inc Company Overview 31<br />
5.12.1 NuVascular Technologies Inc <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview<br />
31<br />
5.13 QT Vascular Ltd. Company Overview 32<br />
5.13.1 QT Vascular Ltd. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 32<br />
5.14 QualiMed Innovative Medizinprodukte GmbH Company Overview 36<br />
5.14.1 QualiMed Innovative Medizinprodukte GmbH <strong>Pipeline</strong> Products & Ongoing Clinical<br />
Trials Overview 36<br />
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreportsbiz<br />
About us<br />
MarketResearchReports.biz is the most comprehensive collection of market research<br />
reports. MarketResearchReports.Biz services are specially designed to save time and money
for our clients. We are a one stop solution for all your research needs, our main offerings<br />
are syndicated research reports, custom research, subscription access and consulting<br />
services. We serve all sizes and types of companies spanning across various industries.<br />
Contact us:<br />
Mr. Nachiket<br />
State Tower<br />
90 Sate Street, Suite 700<br />
Albany, NY 12207<br />
Tel: +15186181030<br />
USA: Canada Toll Free: 8669974948<br />
Website: http://www.marketresearchreports.biz/<br />
E : sales@marketresearchreports.biz
Change language